| www.sas.com > SAS UK > In the Know Homepage | Search | Contact Us |
|
|
|
|
Lord Hunt, Minister for Health, announced this month a new partnership between world leading
business intelligence software company, SAS UK, and the NHS Counter Fraud Service (CFS), that
will provide a much greater capacity to target fraud in the NHS.
Through the partnership, SAS and the NHS CFS will develop software that examines NHS CFS data on pharmaceutical, dental and optical fraud. Using advanced data analysis and visualisation techniques, the software will be able to indicate where in the NHS fraud is most likely to occur. Lord Hunt said, "Although huge achievements have already been made in reducing fraud against the NHS, there is still work to be done. This is why I am very pleased that we have reached agreement with SAS on this project to develop cutting edge technology to detect NHS fraud. We aim to learn from every example of fraud so that we continuously improve our capacity to detect and stop it." He continued, "We shall be using the most sophisticated technology to target those who would deprive the NHS of the resources it needs for patient care. The reduction in losses already made by the NHS CFS since 1999 and the determination to make further progress are indications that the NHS is better protected against fraud than ever before." "We are pleased to be playing our part in protecting the NHS' resources from fraud so that they can be spent on patient care" said Phil Bond, CEO of SAS UK "We are the market leader in business intelligence software and shall be linking our own expertise with the specialist counter fraud expertise of those in the NHS CFS. We are confident that the NHS and patients will benefit very considerably from this work."
Jim Gee, Director of the NHS CFS added,
"This is a ground breaking agreement involving partnership between our own specialist counter
fraud organisation and market leaders in business intelligence software. Very shortly we will
have in place a fraud detection system worthy of the NHS in the 21st Century."
|